MU Department of Medicine 2011-2013 Annual Report Feb. 2014

62 Annual Report University of Missouri- Columbia Hematology/medical oncology Cont. Jessica Fleagle, DO Learning to Provide Better Care in Teams: Co-Principal Investigator Investigator The Next Steps, Donald W. Reynolds Columbia Cystic Fibrosis Pulmonary and International, Randomized, Double-Blind, Foundation, $249,812, 01/01/2013 to Gastroenterology Center FY13, Cystic Controlled Study of Rindopepimut/ 12/31/2013 Fibrosis Foundation, $66,416, 07/01/2012 06/30/2012 Co-Investigator to 06/30/2013 GM-CSF with Adjuvant Temozolomide in Patients with Newly Diagnosed, Surgically Leslie Hall, MD Resected, EGFRvIII-positive Glioblastoma, Principal Investigator Co-Principal Investigator Novella, $1,632, 09/01/2012 to Faculty Development in Inter-professional Columbia Cystic Fibrosis Pulmonary and 08/31/2015 Team-Based Care, Josiah Macy Jr. Gastroenterology Center FY14, Cystic Foundation, $149,588, 03/01/2012 to Fibrosis Foundation, $67,010, 07/01/2013 02/28/2013 to 06/30/2014 International, Randomized, Double-Blind, Melissa Kouba, MD Rochelle Parker, MD Controlled Study of Rindopepimut/ Principal Investigator Co-Investigator GM-CSF with Adjuvant Temozolomide in University of Missouri, Care of the Adult Learning to Provide Better Care in Teams: Patients with Newly Diagnosed, Surgically with CF, Cystic Fibrosis Foundation, The Next Steps, Donald W. Reynolds Resected, EGFRvIII-positive Glioblastoma, $27,000, 07/01/2008 to 06/30/2011 Foundation, $249,812, 01/01/2013 to Dong Xiang, MD Investigator 12/31/2013 Novella, $1,632, 09/01/2012 to 08

MU Department of Medicine 2011-2013 Annual Report Feb. 2014 | Page 62